Skip to content

Cardiac Rehabilitation in Coronary Artery Bypass Graft Surgery

The Effects of Preoperative and Postoperative Cardiac Rehabilitation in Patients Undergoing Coronary Artery Bypass Graft Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07006441
Enrollment
30
Registered
2025-06-05
Start date
2024-08-01
Completion date
2025-08-01
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft Surgery, Coronary Artery Disease

Keywords

Coronary Artery Disease, Coronary Artery Bypass Graft Surgery, Preoperative Cardiac Rehabilitation, Postoperative Cardiac Rehabilitation

Brief summary

This randomized controlled trial investigates the comparative effects of a combined preoperative and postoperative cardiac rehabilitation program versus a postoperative-only program on functional capacity, pulmonary function, peripheral muscle strength, pain, kinesiophobia, and quality of life in patients undergoing coronary artery bypass graft (CABG) surgery. The study aims to determine whether initiating rehabilitation prior to surgery improves short-term postoperative outcomes.

Interventions

OTHERPreoperative Cardiac Rehabilitation

Structured exercise program, respiratory physiotherapy, and patient education

Structured exercise program, respiratory physiotherapy, and patient education

Sponsors

Atlas University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized, Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Having undergone coronary artery bypass graft surgery * Ejection Fraction (EF) \> 40% * Being between the ages of 18-65 * Being able to speak, read and understand in their own language * Volunteering to participate in the study

Exclusion criteria

* Having an active or suspected infection * Presence of an active tumour * History of thrombophlebitis or pulmonary embolism within the last 3 months * Having an orthopaedic, neurological or cardiovascular disease that may affect the assessments

Design outcomes

Primary

MeasureTime frameDescription
Cough Peak Flow2 weeksCough Peak Flow (CPF) will be measured using a peak expiratory flow meter. Participants will be instructed to take a maximal deep breath and then cough as forcefully as possible into the device; the highest value from three trials will be recorded in liters per minute (L/min). Measurements will be performed in a seated position, ensuring a tight mouth seal and consistent technique.
6-minute Walk Test2 weeksThe 6-minute Walk Test will be performed according to ATS guidelines. Walking distance, minute ventilation, respiratory rate, inspiratory capacity and breathing reserve will be recorded.
M. Quadriceps Muscle Strength2 weeksThe m. quadriceps muscle strength will be measured using the MicroFet 2 hand-held dynamometer (Hogan Health Industries, USA). The test will be repeated three times for the dominant side and the average value in kilograms (kg) will be recorded.
M. Biceps Muscle Strength2 weeksThe m. biceps muscle strength will be measured using the MicroFet 2 hand-held dynamometer (Hogan Health Industries, USA). The test will be repeated three times for the dominant side and the average value in kilograms (kg) will be recorded.
Forced Vital Capacity (FVC)2 weeksForced Vital Capacity will be measured before six-minute walk test according to the guideline of ERS.
Forced Expiratory Volume in 1 second (FEV1)2 weeksForced Expiratory Volume in 1 second will be measured before six-minute walk test according to the guideline of ERS.
Peak Expiratory Flow (PEF)2 weeksPeak Expiratory Flow will be measured before six-minute walk test according to the guideline of ERS.
Forced Expiratory Flow 25-75% (FEF25-75)2 weeksForced Expiratory Flow 25-75% will be measured before six-minute walk test according to the guideline of ERS.

Secondary

MeasureTime frameDescription
Level of Fear of Movement2 weeksFear of movement (kinesiophobia) will be assessed using the Tampa Scale for Kinesiophobia (TSK). Participants will complete the 17-item questionnaire, which evaluates fear of movement and re-injury on a 4-point Likert scale. The total score, ranging from 17 to 68, will be calculated, with higher scores indicating greater fear of movement.
Level of Quality of Life2 weeksQuality of life will be assessed using the Short Form-36 (SF-36) Health Survey. Participants will complete the 36-item questionnaire, which evaluates eight domains including physical functioning, bodily pain, general health, and mental well-being. Each domain will be scored from 0 to 100, with higher scores indicating better perceived quality of life.
Level of Pain2 weeksPain assessment will be performed using the Visual Analog Scale (VAS) to evaluate chest pain levels. Participants will be asked to mark their current pain intensity on a 10 cm horizontal line, with no pain at one end and worst imaginable pain at the other. The distance in centimeters from the no pain end to the mark will be measured and recorded as the pain score.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026